Impact Factor 2024

Search

Search articles for

Advanced filters

Published AfterYearMonthDay

Published BeforeYearMonthDay

By Author

By Section

Search Results

##search.searchResults.foundPlural##

Effects of the availability of new oral anticoagulants in patients with non-valvular atrial fibrillation in the real world: the NAIF study

Francesco Ventrella, Franco Mastroianni, Sergio Cappello, Luigi Iamele, Samantha Errico, Massimo Errico

176-183

06-07-2016

https://doi.org/10.4081/itjm.2016.715

1471

PDF: 936

HTML: 342
The incidence of bleeding in patients with nonvalvular atrial fibrillation using anticoagulants: a real-world report with the biggest Vietnamese data

Bui The Dung, Cao Ngoc Mai Han, Tran Hoa, Nguyen Thanh Hien

17-02-2025

https://doi.org/10.4081/itjm.2025.1807

1878

PDF: 347

HTML: 1
Assessment and predictors of inappropriate dose of direct oral anticoagulants

Mosaad O. Almegren

09-01-2024

https://doi.org/10.4081/itjm.2024.1679

929

pdf: 463

HTML: 126
Old and new oral anticoagulants for secondary stroke prevention in atrial fibrillation

Tommaso Sacquegna, Anna Zaniboni, Andrea Rubboli, Gaetano Procaccianti, Michela Crisci, Fabiola Maioli, Giorgia Arnone, Giuseppe Di Pasquale

314-322

15-12-2015

https://doi.org/10.4081/itjm.2015.468

1976

PDF: 923

HTML: 1232
Sex-gender and atrial fibrillation treatment in the AntiThrombotic Agents in Atrial Fibrillation (ATA-AF) study

Cecilia Politi, Tiziana Ciarambino, Letizia Riva, Stefania Frasson, Donata Lucci, Gualberto Gussoni, Lucio Gonzini, Mauro Campanini, Michele Gulizia, Giuseppe Di Pasquale, Giovanni Mathieu, on behalf of ATA-AF Steering Committee and Investigators

207-212

16-02-2016

https://doi.org/10.4081/itjm.2016.649

1714

PDF: 1464

Appendix: 686

HTML: 544
Emergency management of patients being treated with oral anticoagulants

Franco Manzato, Massimo Franchini

234-241

17-12-2013

https://doi.org/10.4081/itjm.2013.234

1095

PDF: 865

HTML: 304
The practical management of bleedings during treatment with direct oral anticoagulants: the emergency reversal therapy

Luca Masotti, Giancarlo Landini, Grazia Panigada

48-58

24-12-2013

https://doi.org/10.4081/itjm.2013.s8.48

1388

PDF: 967
Stroke prevention in atrial fibrillation: findings from Tuscan FADOI Stroke Registry

Luca Masotti, Rinaldo Innocenti, Stefano Spolveri, Irene Chiti, Grazia Panigada, Cristiana Seravalle, Giancarlo Landini, Alberto Fortini, Rino Migliacci, Raffaele Laureano, for Tuscan FADOI Stroke Registry Investigators

134-140

12-06-2014

https://doi.org/10.4081/itjm.2014.450

1587

PDF: 1255

Appendix: 579

HTML: 622
Pharmacology of new oral anticoagulants: mechanism of action, pharmacokinetics, pharmacodynamics

Luca Masotti, Mauro Campanini

1-7

24-12-2013

https://doi.org/10.4081/itjm.2013.s8.1

11424

PDF: 2920
Direct oral anticoagulants in real practice: which doses for which patients. Limitations and bleeding risk compared to vitamin K antagonists

Giancarlo Landini, Luca Masotti

41-47

24-12-2013

https://doi.org/10.4081/itjm.2013.s8.41

930

PDF: 825
The treatment of venous thromboembolism with new oral anticoagulants

Davide Imberti

29-35

24-12-2013

https://doi.org/10.4081/itjm.2013.s8.29

1071

PDF: 856
Vorapaxar

Gianluca Airoldi, Mauro Campanini

88-95

24-04-2013

https://doi.org/10.4081/itjm.2013.88

1183

PDF: 669

HTML: 220
Direct oral anticoagulants for secondary prevention in patients with non-valvular atrial fibrillation

Luca Masotti, Mario Di Napoli, Walter Ageno, Davide Imberti, Cecilia Becattini, Maurizio Paciaroni, Daniel Augustin Godoy, Roberto Cappelli, Giancarlo Landini, Grazia Panigada, Ido Iori, Domenico Prisco, Giancarlo Agnelli

8-21

24-12-2013

https://doi.org/10.4081/itjm.2013.s8.8

1320

PDF: 900
A review on management of antiphospholipid syndrome in clinical practice

Carmine Siniscalchi, Pietro Rossetti, Gaetano Carolla, Pierpaolo Di Micco, Adriano Stella, Michele Riva

13-09-2023

https://doi.org/10.4081/itjm.2023.1649

2605

PDF: 1052

HTML: 82
Monitoring strategies for patients treated with the new oral anticoagulants and the need for laboratory evaluation of hemostasis

Andrea Fontanella, Pierpaolo Di Micco

59-64

24-12-2013

https://doi.org/10.4081/itjm.2013.s8.59

932

PDF: 914
Pharmacological interactions in novel oral anticoagulants, statins, and hypertension drugs in patients treated with direct-acting antivirals for hepatitis C: a Delphi Consensus project

Ivan Gentile, Giancarlo Agnelli, Angelo Avogaro, Claudio Borghi, Alessia Ciancio, Ernesto Claar, Patrizio Pasqualetti, Pasquale Perrone Filardi

25-11-2024

https://doi.org/10.4081/itjm.2024.1846

1013

PDF: 368

SUPPLEMENTARY MATERIAL: 231

ACKNOWLEDGMENTS: 219

HTML: 110
New oral anticoagulants: key messages for clinicians

Matteo Giorgi-Pierfranceschi, Chiara Cattabiani, Francesco Dentali

74-84

24-12-2013

https://doi.org/10.4081/itjm.2013.s8.74

1276

PDF: 887
Apixaban

Gianluca Airoldi, Mauro Campanini

128-134

07-03-2013

https://doi.org/10.4081/itjm.2011.128

1183

PDF: 1882
Cryptogenic stroke

Michele Stornello, Roberto Cappellani, Giuseppe Micieli, Simona Sacco, Stefano Spolveri, Roberto Sterzi, Danilo Toni, Antonio Carolei

185-194

30-09-2016

https://doi.org/10.4081/itjm.2016.682

1916

PDF: 1113

HTML: 586
Newer non-vitamin K-antagonist direct oral anticoagulants in acute coronary syndromes

Andrea Rubboli

22-28

24-12-2013

https://doi.org/10.4081/itjm.2013.s8.22

1000

PDF: 754
Pregnancy and heart disease: what Internists should know

Riccardo Gerloni, Domenico Panuccio

288-304

11-09-2017

https://doi.org/10.4081/itjm.2017.815

1353

PDF: 696

HTML: 266
Characteristics and clinical management of acute pulmonary embolism in real world: findings from TUSCAN-PE study

Luca Masotti, Filippo Pieralli, Grazia Panigada, Francesco Corradi, Rino Migliacci, Salvatore Lenti, Alessandro Tafi, Carlo Nozzoli, Giancarlo Landini, for TUSCAN-PE Investigators

125-133

03-06-2014

https://doi.org/10.4081/itjm.2014.504

2123

PDF: 1352

Appendix: 1099

HTML: 757
Efficacy and safety of new oral anticoagulants compared with warfarin in cardioembolic prophylaxis of patients with non valvular atrial fibrillation. More lights than shadows

Luca Masotti, Mario Di Napoli, Walter Ageno, Davide Imberti, Daniel Godoy, Grazia Panigada, NiccolÃ² Napoli, Giancarlo Landini, Roberto Cappelli, Ido Iori, Domenico Prisco, Giancarlo Agnelli

153-169

23-10-2012

https://doi.org/10.4081/itjm.2012.153

1687

PDF: 2011
Clinical characteristics of very old patients hospitalized in internal medicine wards for heart failure: a sub-analysis of the FADOI-CONFINE Study Group

Paolo Biagi, Roberto Nardi, Concetta Isabella Baldo, Giovanni Scanelli, Domenico Panuccio, Andrea Bonanome, Fabio Miserocchi, Luigi Lusiani, Erminio Bonizzoni, Mauro Campanini, Carlo Nozzoli, Giorgio Vescovo, on behalf of the FADOI-CONFINE Study Group

19-28

17-03-2014

https://doi.org/10.4081/itjm.2014.394

2033

PDF: 1124

HTML: 657
How to manage new oral anticoagulants in case of surgery

Davide Imberti

36-40

24-12-2013

https://doi.org/10.4081/itjm.2013.s8.36

929

PDF: 833
Clinical management of spontaneous intracranial haemorrhage associated with oral anticoagulants: a case series

Luca Masotti, Alessandro Pampana, Paolo Pennati, Giancarlo Landini

34-44

07-03-2013

https://doi.org/10.4081/itjm.2011.34

777

PDF: 1022
Results of prospective multicenter study on heart failure on Campania Internal Medicine wards: the FASHION study

Fernando Gallucci, Ilaria Ronga, Andrea Fontanella, Generoso Uomo, and the FASHION Study Group

184-190

14-06-2017

https://doi.org/10.4081/itjm.2017.705

1384

PDF: 747

HTML: 451
Portal vein thrombosis and Budd-Chiari syndrome as onset of polycythemia vera

Aurelio Seidita, Delia Sprini, Accursia BongiovÃ¬, Tiziana Catalano, Filippo Barbiera, Maria Accardi, Pasquale Mansueto, Antonio Carroccio

196-205

19-09-2013

https://doi.org/10.4081/itjm.2013.196

1873

PDF: 1091

HTML: 1923
Sex differences in adverse drug reaction and liver disease

Ombretta Para, Pietro Crispino, Nunzia Barone, Sara Macis, Laura Airasca, Paola Gnerre, Cecilia Politi

15-22

20-03-2018

https://doi.org/10.4081/itjm.2018.893

2068

PDF: 915

HTML: 460
Thrombophilias: therapeutic employment of direct oral anticoagulants in venous hypercoagulable states

Federico Cacciapuoti

136-142

17-09-2020

https://doi.org/10.4081/itjm.2020.1296

822

PDF: 534

HTML: 361
Patent foramen ovale and ischemic stroke: more shadows than lights? What the internist should know

Andrea Donti

175-184

30-09-2016

https://doi.org/10.4081/itjm.2016.676

1598

PDF: 944

HTML: 924
Management of major bleeding in patients treated with direct oral anticoagulants: from experience to standardized protocols

Sara Mascia, Anna Maria Ferrari, Nicola Macarone Palmieri, Elisa Romagnoli, Chiara Catena, Serena Scarabottini, Francesca Mori, Lucio Brugioni

43-48

17-06-2020

https://doi.org/10.4081/itjm.2020.1224

951

PDF: 633

HTML: 196
Embolic stroke of undetermined source: a retrospective analysis from an Italian Stroke Unit

Marco Masina, Annalena Cicognani, Carla Lofiego, Simona Malservisi, Riccardo Parlangeli, Alessandro Lombardi

202-206

30-09-2016

https://doi.org/10.4081/itjm.2016.690

1662

PDF: 872

HTML: 803
A dangerous adverse event in the use of dabigatran

Manuel Monti, Giovanni Maria Vincentelli, Francesco Borgognoni, Giuseppe Murdolo, Feliciano Menghini

250-251

09-11-2015

https://doi.org/10.4081/itjm.2015.629

1614

PDF: 913

HTML: 254
Treatment and secondary prophylaxis of venous thromboembolism with direct oral anticoagulants in patients with severe hereditary thrombophilia

Pasquale Madonna, Anna Guida, Maria Gabriella Coppola, Paolo Tirelli, Ernesto Grasso

18-03-2021

https://doi.org/10.4081/itjm.2021.1351

1137

PDF: 538

HTML: 54
The heart failure in Internal Medicine in Tuscany: the SMIT Study

Valerio Verdiani, Grazia Panigada, Alberto Fortini, Luca Masotti, Simone Meini, Paolo Biagi, for the SMIT Study Group

349-355

15-12-2015

https://doi.org/10.4081/itjm.2015.554

1642

PDF: 904

Appendix: 1015

HTML: 754
Differences in in-hospital clinical course, management and outcome between stroke with and without atrial fibrillation. A retrospective analysis from the SETI (Studio Epidemiologico Toscano Ictus) study

P. Biagi, S. Bocchini, R. Laureano, G. Panigada, G. Vescovo

14-22

03-05-2013

https://doi.org/10.4081/itjm.2007.4.14

1007

PDF: 771
The management of the patient with acute pancreatitis: from evidence to clinical practice

Cristina Cenci, Tea Restuccia, Paola Gnerre, Irene Chiti, Laura Betti, Milena Micati, Claudio Tana

220-245

11-09-2017

https://doi.org/10.4081/itjm.2017.748

2706

PDF: 1209

HTML: 1342
Gender medicine: an up-date

Cecilia Politi, Tiziana Ciarambino, Flavia Franconi, Lucrezia De Feudis, Maria Carolina Mayer, Alessandra Martignoni, Ilaria Giovi, Michela Tonani, Salvatore La Carrubba, Anna Maria Moretti, Carmen Martino, Giovanni Scanelli

96-106

24-04-2013

https://doi.org/10.4081/itjm.2013.96

2129

PDF: 923

HTML: 471
Acute severe renal failure in a patient receiving apixaban: a case report

Attilia Maria Pizzini, Chiara Fantoni, Stefania Zaccaroni, Mauro Silingardi

09-04-2024

https://doi.org/10.4081/itjm.2024.1718

626

PDF: 428

HTML: 71
The FADOI (Federation of Associations of Hospital Doctors on Internal Medicine) position paper on cardiovascular prevention in the higher risk complex patients

Mauro Campanini, Giuliano Pinna, Roberto Nardi, on behalf of the FADOI Cardiovascular Prevention Position Statements Group

387-404

15-12-2015

https://doi.org/10.4081/itjm.2015.669

2122

PDF: 885

Appendix: 473

HTML: 1459
Optimal duration of anticoagulant therapy in patients with venous thromboembolism

Gualtiero Palareti

235-244

14-09-2018

https://doi.org/10.4081/itjm.2018.1077

1489

PDF: 1785

HTML: 260
Anticoagulation in the early phase of non-valvular atrial fibrillation-related acute ischemic stroke: where do we stand?

Luca Masotti, Elisa Grifoni, Alessandro Dei, Vieri Vannucchi, Federico Moroni, Grazia Panigada, Stefano Spolveri, Giancarlo Landini

24-31

03-01-2019

https://doi.org/10.4081/itjm.2019.1111

1390

PDF: 787

HTML: 71
Abdominal pain: a synthesis of recommendations for its correct management

Daniela Tirotta, Annalisa Marchetti, Mariangela Di Lillo, Fulvio Pomero, Roberta Re, Michele Meschi, Domenico Montemurro, Paola Gnerre, Chiara Bozzano, Micaela La Regina

193-202

08-05-2015

https://doi.org/10.4081/itjm.2015.515

3808

PDF: 1445

Appendix: 550

HTML: 8941
Generic - equivalent drugs use in internal and general medicine patients: distrust, confusion, lack of certainties or of knowledge? Part 3. Clinical issues

Roberto Nardi, Marco Masina, Giorgio Cioni, Paolo Leandri, Paola Zuccheri

99-109

08-05-2014

https://doi.org/10.4081/itjm.2014.400

2256

PDF: 1375

HTML: 717
Management of stable coronary artery disease: from evidence to clinical practice

Riccardo Gerloni, Luciano Mucci, Tiziana Ciarambino, Manuel Ventura, Valeria Baglio, Massimiliano Chiuch, Francesca Saladini, Stefania Dorigoni, Davide Tizzani, Paola Gnerre

114-133

14-06-2017

https://doi.org/10.4081/itjm.2017.755

2652

PDF: 1147

HTML: 1735
Equivalent/generic drugs use. To whom? When? How?

Andrea Fontanella

77-79

08-05-2014

https://doi.org/10.4081/itjm.2014.472

1043

PDF: 799

HTML: 247
How artificial intelligence during the pandemic modified the role of a biomarker as d-dimer

Pierpaolo Di Micco, Francesca Futura Bernardi, Giovanni Maria Fusco, Alessandro Perrella

20-11-2023

https://doi.org/10.4081/itjm.2023.1656

995

PDF: 346

HTML: 30
The management of heart failure: a FADOI survey in the setting of Internal Medicine Units

Fernando Gallucci

16-02-2023

https://doi.org/10.4081/itjm.2023.1573

1925

PDF: 570

HTML: 13
An unusual cause of massive hemoptysis

Silvia Maestroni, Martino Cellerini, Antonio Brucato

71-74

01-07-2016

https://doi.org/10.4081/itjm.2016.738

1327

PDF: 860

HTML: 380

1 - 50 of 52 items 1 2 > >>

© PAGEPress 2008-2025 • PAGEPress^® is a registered trademark property of PAGEPress srl, Italy • VAT: IT02125780185 • Privacy